S. Belo Ravara (Covilhã, Portugal), E. Dagli (Istanbul, Turkey)
Late Breaking Abstract - Differences in flavorant levels and synthetic coolant use between USA, EU and Canadian Juul products
H. Erythropel (New Haven, United States of America), P. Anastas (New Haven, United States of America), S. Krishnan-Sarin (New Haven, United States of America), S. O'Malley (New Haven, United States of America), S. Jordt (Durham, United States of America), J. Zimmerman (New Haven, United States of America)
|     |
Treatment complication rates in continued smokers vs quitters after a diagnosis of lung cancer: a cohort study
K. Lanyon (Swansea, United Kingdom), R. Gemine (llanelli (Dyfed), United Kingdom), G. Davies (llanelli (Dyfed), United Kingdom), K. Lewis (llanelli (Dyfed), United Kingdom)
| |
Flavor-solvent reaction products in electronic cigarette liquids activate respiratory irritant receptors and elicit cytotoxic metabolic responses in airway epithelial cell
S. Jordt (Durham, NC, United States of America), A. Caceres (Durham, NC, United States of America), H. Erythropel (New Haven, CT, United States of America), J. Zimmerman (New Haven, CT, United States of America), T. Dewinter (New Haven, CT, United States of America), S. Jabba (Durham, NC, United States of America)
| |
Outpatient smoking cessation: preliminary findings of a non-inferiority RCT comparing blended with face-to-face delivery mode
L. Siemer (Enschede, Netherlands), M. Pieterse (Enschede, Netherlands), S. Ben Allouch (Amsterdam, Netherlands), M. Postel (Enschede, Netherlands), R. Sanderman (Groningen, Netherlands), M. Brusse-Keizer (Enschede, Netherlands)
| |
Asthma do not counteract smoking initiation
L. Hedman (Umeå, Sweden), H. Backman (Umeå, Sweden), M. Andersson (Umeå, Sweden), C. Stridsman (Umeå, Sweden), E. Rönmark (Umeå, Sweden)
| |
Acute health effects after passive e-vape among patients with COPD – an RCT exposure study
K. Rosenkilde Laursen (Aarhus, Denmark), J. H. Bønløkke (Ålborg, Denmark), M. Bilde (Aarhus, Denmark), M. Glasius (Aarhus, Denmark), E. Bendstrup (Aarhus, Denmark), S. K. Kjærgaard (Aarhus, Denmark), A. Olin (Gothenburg, Sweden), T. Sigsgaard (Aarhus, Denmark)
| |
Evolution in disease severity during the E-cigarette or Vaping-Associated Lung Injury (EVALI) outbreak
M. Lanspa (Salt Lake City, United States of America), D. Harris (Salt Lake City, United States of America), B. Anderson (Parker, United States of America), S. Callahan (Salt Lake City, United States of America), S. Rea (Salt Lake City, United States of America), D. Collingridge (Salt Lake City, United States of America), D. Guidry (Salt Lake City, United States of America), C. Grissom (Salt Lake City, United States of America), D. Blagev (Salt Lake City, United States of America)
| |
Association of low-intensity smoking with respiratory and lung cancer mortality
P. Balte (New York, United States of America), S. Bhatt (Birmingham, United States of America), P. Chaves (Miami, United States of America), D. Couper (Chapel Hill, United States of America), N. Freedman (Rockville, United States of America), D. Jacobs Jr (Minneapolis, United States of America), M. Jones (Baltimore, United States of America), R. Kalhan (Chicago, United States of America), A. Mathew (Chicago, United States of America), R. Kronmal (Seattle, United States of America), L. Loehr (Chapel Hill, United States of America), S. London (Research Triangle park, United States of America), A. Newman (Pittsburgh, United States of America), G. O'Connor (Boston, United States of America), J. Schwartz (New York, United States of America), B. Smith (New York, United States of America), L. Smith (Chicago, United States of America), W. White (Jackson, United States of America), S. Yende (Pittsburgh, United States of America), E. Oelsner (New York, United States of America)
| |